Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party

Marsh, Judith; Socie, Gerard; Tichelli, Andre; Schrezenmeier, Hubert; Hochsmann, Britta; Risitano, Antonio M.; Fuehrer, Monika; Bekassy, Albert N.; Korthof, Elizabeth T.; Locasciulli, Anna; Ljungman, Per; Bacigalupo, Andrea; Camitta, Bruce; Young, Neal S.; Passweg, Jakob

doi:10.1111/j.1365-2141.2010.08200.x

Scientific article

Letter

English

Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party

ContributorsMarsh, Judith; Socie, Gerard; Tichelli, Andre; Schrezenmeier, Hubert; Hochsmann, Britta; Risitano, Antonio M.; Fuehrer, Monika; Bekassy, Albert N.; Korthof, Elizabeth T.; Locasciulli, Anna; Ljungman, Per; Bacigalupo, Andrea; Camitta, Bruce; Young, Neal S.; Passweg, Jakob

Published inBritish journal of haematology, vol. 150, no. 3, p. 377-379

Publication date2010

Keywords

Anemia, Aplastic/*therapy
Antilymphocyte Serum/*therapeutic use
Blood/radiation effects
Blood Component Transfusion/*utilization
Bone Marrow Transplantation
Graft vs Host Disease/prevention & control
Health Care Surveys
Humans
Immunosuppressive Agents/*therapeutic use

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Citation (ISO format)

MARSH, Judith et al. Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party. In: British journal of haematology, 2010, vol. 150, n° 3, p. 377–379. doi: 10.1111/j.1365-2141.2010.08200.x

Article

Identifiers

PID : unige:21117
DOI : 10.1111/j.1365-2141.2010.08200.x
PMID : 20528874

Additional URL for this publicationhttp://onlinelibrary.wiley.com/store/10.1111/j.1365-2141.2010.08200.x/asset/j.1365-2141.2010.08200.x.pdf?v=1&t=h1qh3dxp&s=0cafc2c68e3501a1df127e323d0f4a40af8e77ef

Journal ISSN0007-1048

546views

0downloads

Creation23/05/2012 08:53:00

First validation23/05/2012 08:53:00

Update14/03/2023 17:34:25

Status update14/03/2023 17:34:24

Last indexation29/10/2024 20:04:47

Archive ouverte UNIGE

Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party

Technical informations